Replies

Embryonic stem cells come from an embryo. An embryo is an individual, genetically-distinct human-being, a baby. And we cannibals in America harvest these babies for their body parts. It's sort of like a baby parts factory. We make them in fertility clinics, about 360 of them found in many towns across America, where parents create a bunch of babies in a test tube, In-Vitro Fertilization, (IVF) implant some, where some are aborted and if they're lucky one will implant and grow to term while the parents' other children are put on ice, a Gulag of sorts, until the babies are sold to labs where their parts will be used. There are an estimated 400,000 babies on ice right now in the USA.

This research is legal so long as private and state money is used where NJ and CA are in the process of funding embryonic stem cell research and cloning. Federal funding is available to only the lines already in use. It's wrong but it's better than starting new lines of humans for research. NJ goes further and allows the cloned baby to grow to term where it is legal to kill it after he/she reaches 9 months! All in the name of Science.

When you read this article, it may be more of a reality for you.

Tim and Mary artificially conceived 15 children, after their conception their children weren't in a warm 98.6 degree surrounding inside their mother. NO they were sent to the Gulag and put on ice for a few weeks. 6 of her CHILDREN were thawed like a piece of steak, and the so-called 3 "viable" were implanted which means the other 3 unviable were thrown in the garbage (aborted by the human hand)? The article didn't say. She is now pregnant with twins which means the other child didn't make it and was aborted. So, the 3 unviable thawed children were "aborted" or thrown in the garbage before implantation and the other one of the 3 implanted was aborted from inside the mother. Notice they didn't say how it happened or what happened to the embryo/baby.

The article further asks this question, "What should they do with any unused frozen embryos?" or should the article say what should they do with the 9 children they already have on ice or what the parents should do to the rest of THEIR CHILDREN they created! How are they going to explain or rationalize the facts to their grown children if they ever ask or find out how they were created?

Well instead of adopting a child we decided to create 15 children, the two of you were lucky enough to grow to term, 3 of your brothers and sisters didn't thaw correctly and had to be discarded like a freezer-burned hamburger and the rest of your 9 brothers and sisters (probably still alive in a lab or freezer) have been sentenced to death where they were sent to a Gulag awaiting to be harvested for their parts all in the name of science in a country were INDIVIDUAL rights, based on biblical principals, were supposed to have been granted by law.

Notice one option is to have the embryos "adopted" by another couple. That hardly happens, that's why there are 400,000 babies on ice.

Hey, why didn't Tim and Mary adopt in the first place? Adoption the loving option, Adoption not Abortion.

Why create 15 human lives where only 2 survived when all they could have done was to adopt a child already born, just waiting for a loving family and home?

Actress Brooke Shields killed some of her very own Children by undergoing 7 IVF Treatments

Adult Stem Cell use, ( an ethical and effective approach), is a process by which stem cells are taken from: umbilical cord blood, bone marrow, fat cells, nasal cells and elsewhere have been PROVEN successful, some as long as 30 years, in many instances where cancer was cured and spinal cord victims regained the "limited" use and sensation of their arms and legs. We should continue to use something that is proven ethical and effective, let your representatives know how you feel.

Zygotes and embryos are people and so is soilent green, looks like the Charlton Heston sci-fi movie wasn't so far-fetched or fiction for that matter.

Harvesting Fetal Body Parts

“A Catholic person who actually procures an abortion occurs a latae sententiae excommunication.”

What's that giant sucking sound I hear in Sacramento? Could it be our borrowed money going down the tubes?

FYI

And we just threw away THREE BILLION DOLLLARS in CA for embryonic stem cell research. Which will cost us another THREE BILLION DOLLARS to pay off...

Thank you, governor!

And all the while, umbilical blood stem cells are effective, proven, and waiting to be ethically explored. What a waste ...

Adult stem cells work there is NO need to harvest babies for their body parts.

Embryo Vivisection and Elusive Promises Act--California Stem Cell Research and Cures Initiative

Abortion and the selling of infant body parts is a very lucrative business.

As my wife works in Stanford's reproductive endocrinology clinic, she has been aware of this for some time. I'm glad to see it hitting the mainstream.

From the journal Nature, no less.
ProLife Ping!

If anyone wants on or off my ProLife Ping List, please notify me here or by freepmail.

Stem-cell stocks damaged by study
Researchers see culturing contaminating stem cells

By Val Brickates Kennedy, MarketWatch
Last Update: 6:01 PM ET Jan. 24, 2005

E-mail it | Print | Alert | Reprint | RSS

BOSTON (MarketWatch) -- Shares of three stem cell-related companies fell sharply Monday after a study asserted the bulk of embryonic stem cells used for U.S. research are contaminated and may not be suitable to transplant into humans.

Shares of Aastrom Biosciences (ASTM: news, chart, profile) closed down nearly 20 percent at $3.23.

StemCells Inc. (STEM: news, chart, profile) , meanwhile, fell almost 16 percent to $4.99, and Geron Corp. (GERN: news, chart, profile) lost 6.29 percent to $8.04. Shares of the newly public ViaCell Inc. (VIAC: news, chart, profile) appeared to be unscathed, moving up about 5.01 percent to $9.12.

The study, conducted at the University of California in San Diego and the Salk Institute, blamed the contamination on animal-derived culturing agents that scientists use to grow embryonic stem cells.

Reports of such contamination are not new. Proponents of creating new embryonic-stem-cell lines have often said that the culturing agents, most of which contain mouse cells, have contaminated key stem-cell lines used in basic research.

Yet while the news is of considerable importance to scientists engaged in academic research, it is not likely to have as much of an impact on stem cell companies, few of which are engaged in embryonic stem cell cultivation.

"[The stem-cell-related stocks] are all moving because nobody knows the differences between the companies. They move as a group, rightly or wrongly," said Stephen Dunn, an analyst for Dawson James Securities, who tracks stem-cell companies including Aastrom.

In a report to be published in the February edition of the journal Nature Medicine, the UC-San Diego and Salk researchers posit that most of the nation's embryonic-stem-cell lines, groups of cells culled from human embryos, have been contaminated by foreign genetic material.

Because of this contamination, the researchers believe the embryonic cells could trigger a severe immunological reaction if transplanted into humans for therapeutic purposes.

Fred Gage, a leading researcher for the Salk Institute and a founder of StemCells Inc., was a key member of the research team, according to Nature Medicine's Web site.

Stem cells are primitive cells that have the ability to transform themselves into the more specialized cells that make up the human body. Scientists have been seeking ways to use the cells to repair damage caused by disease or injury.

Embryonic stem cells are culled from days-old embryos donated by fertility clinics. Stem cells can also be derived from tissues in the human body and blood found in umbilical cords.

While StemCells, Aastrom, Geron and ViaCell all are working on stem-cell therapies, the types of cells they have used and how they have been cultured vary greatly.

StemCells, for example, uses fetal stem cells for its leading stem-cell therapy product. That product is currently in Phase I clinical trials for the treatment of Batten disease, a fatal genetic disorder that affects the central nervous system.

The stem cells are derived from donated brain tissue from miscarried, stillborn or aborted babies, according to StemCells Chief Executive Martin McGlynn.

"We're not engaged in embryonic stem-cell research," said McGlynn late Monday. McGlynn added that the stem cells are cultivated in a media that doesn't use any animal or human-derived "feeder" cells to help them grow.

Meanwhile, Aastrom also emphasizes it does not use embryonic stem cells in its products. Aastrom is conducting Phase I clinical trials on a product that takes stem cells from a patient's own bone marrow and replicates them for transplantation to heal severe bone fractures.

A spokeswoman for Aastrom said Monday that the company did not grow its therapeutic stem cells in any media that employs mouse cells.

Dunn said he recently lowered his rating on Aastrom from "buy" to "neutral" due to the stock's high valuation.

Geron Corp., which saw a far narrower swing in its stock, has had a long-standing program engaged in embryonic stem-cell research. The company's work, however, has been more focused on developing cancer drugs based on the enzyme telomerase.

Breaking from the pack on Monday was newcomer ViaCell, which held its initial public offering Friday, offering 7.5 million shares at $7 a share.

While ViaCell has a stem-cell-based therapy in Phase I clinical trials, the company's revenue is mainly derived from storage services for umbilical-cord blood for future therapeutic use. ViaCell's stem-cell products are derived from umbilical-cord blood.